Stark, Roderick Thomas
2020.
Synthesis of 2’-bromo-2’-fluoro-2’-deoxycytidine derivatives towards [18F]gemcitabine.
PhD Thesis,
Cardiff University.
Item availability restricted. |
Preview |
PDF
- Accepted Post-Print Version
Download (7MB) | Preview |
![]() |
PDF (Cardiff University Electronic Publication Form)
- Supplemental Material
Restricted to Repository staff only Download (122kB) |
Abstract
Gemcitabine is a frequently used chemotherapeutic agent against a range of cancers – pancreatic cancer in particular. One of its disadvantages is its poor specificity, needing to overcome many deactivation pathways in order to impart its anticancer properties. As such, a fluorine-18 labelled gemcitabine would provide in vivo pharmacokinetic information specific for each patient in a step towards personalised treatment. Herein described is a synthetic route towards compounds that may be screened as a fluorine-18 radiolabelling precursors for the synthesis of [18F]gemcitabine. The developed strategy centres on the synthesis of key 2-bromo-2-fluororibonolactone, which was produced in a diastereoselective fashion. The synthesised lactone was then reacted with cytosine derivatives to deliver the radiofluorination substrates. Fluorination with fluorine-19 demonstrated the suitability of the substrates towards substitution, with initial [18F]fluorination studies also conducted. Tissue culture studies were also carried out, in order to evaluate the bioactivity of the synthesised compounds, relative to gemcitabine.
Item Type: | Thesis (PhD) |
---|---|
Date Type: | Completion |
Status: | Unpublished |
Schools: | Chemistry |
Date of First Compliant Deposit: | 23 September 2020 |
Last Modified: | 23 Sep 2021 01:30 |
URI: | https://orca.cardiff.ac.uk/id/eprint/135062 |
Actions (repository staff only)
![]() |
Edit Item |